Vitamin D and colon cancer

Expert Review of Gastroenterology and Hepatology

Volumn 5, Issue 1, 2011, Pages 67-81

  Davis, Cindy D ^a   Milner, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

colon cancer; CYP24A1; CYP27B1; vitamin D; vitamin D receptor

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; BETA CATENIN; BIOLOGICAL MARKER; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CYTOCHROME P450; CYTOCHROME P450 CYP24A1; CYTOCHROME P450 CYP27B; GENISTEIN; PLACEBO; UNCLASSIFIED DRUG; UVOMORULIN; VITAMIN D; VITAMIN D RECEPTOR;

ADENOMATOUS POLYP; ANTINEOPLASTIC ACTIVITY; CALORIC INTAKE; CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; COLON CANCER; COLORECTAL ADENOMA; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; ENERGY EXPENDITURE; EXERCISE INTENSITY; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; NONHUMAN; NUTRITIONAL STATUS; RACE DIFFERENCE; RECURRENT CANCER; REVIEW; RISK REDUCTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; ENERGY METABOLISM; HUMANS; INCIDENCE; RISK FACTORS; VITAMIN D;

EID: 79951612405     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.10.89     Document Type: Review

References (125)

1. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J. Clin. Endocrinol. Metab. 89(11), 5387-5391 (2004). (Pubitemid 39518413)
2. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am. J. Clin. Nutr. 68(4), 854-858 (1998). (Pubitemid 28471068)
3. Holick MF, Biancuzzo RM, Chen TC et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 93(3), 677-681 (2008). (Pubitemid 351398538)
4. Biancuzzo RM, Young A, Bibuld D et al. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am. J. Clin. Nutr. 91(6), 1621-1626 (2010).
5. Springbett P, Buglass S, Young AR. Photoprotection and vitamin D status. J. Photochem. Photobiol. B 101(2) 160-168 (2010).
6. Armas LA, Dowell S, Akhter M et al. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J. Am. Acad. Dermatol. 57(4), 588-593 (2007). (Pubitemid 47384914)
7. Webb AR, DeCosta BR, Hollick MF. Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J. Clin. Endocrinol. Metab. 68(5), 882-887 (1989). (Pubitemid 19127404)
8. Ohyama Y, Yamasaki T. Eight cytochrome P450s catalyze vitamin D metabolism Front. Biosci. 1(9), 3007-3018 (2004).
9. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 29(12), 664-673 (2004). (Pubitemid 39491265)
10. Campbell MJ, Adorini L. The vitamin D receptor as a therapeutic target. Expert Opin. Ther. Targets 10(5), 735-748 (2006). (Pubitemid 44479981)
11. Pendas-Franco N, Aguilera O, Pereira F, Gonz?lez-Sancho JM, Munoz A. Vitamin D and Wnt/b-catenin pathway in colon cancer: role of the regulation of Dickkopf genes. Anticancer Res. 28(5A), 2613-2624 (2008).
12. Cranney A, Horsely T, O'Donnell S et al. Effectiveness and safety of vitamin D in relation to bone health. Evid. Rep. Technol. Assess. 158, 1-235 (2007).
13. Jones G. Pharmacokinetics of vitamin D toxicity. Am. J. Clin. Nutr. 88(2), S582-S586 (2008).
14. Platz EA, Hankinson SE, Hollis BW et al. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol. Biomarkers Prev. 9(10), 1059-1065 (2000).
15. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. In:Dietary Reference Intakes for Calcium and Vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB (Eds). The National Academies Press, Washington DC, USA (2010).
16. Jones G. Pharmacokinetics of vitamin D toxicity. Am. J. Clin. Nutr. 88(2), S582-S586 (2008).
17. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9(3), 227-231 (1980). (Pubitemid 11238851)
18. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 8424(1), 307-309 (1985). (Pubitemid 15157126)
19. Benito E, Stiggelbout A, Bosch FX et al. Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int. J. Cancer 49(2), 161-167 (1991).
20. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Fosom AR. Relation of calcium, vitamin D and dairy food intake to incidence of colon cancer among older women. Am. J. Epidemiol. 127(12), 1302-1317 (1993). (Pubitemid 23215031)
21. Pritchard RS, Baron JA, Gerhardsson de Verdier M. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol. Biomarkers Prev. 5(11), 897-900 (1996). (Pubitemid 26382983)
22. Martinez ME, Giovannucci EL, Coldizt GA et al. Calcium, vitamin D and the occurrence of colorectal cancer among women. J. Natl Cancer Inst. 88(19), 1375-1382 (1996). (Pubitemid 26329755)
23. Kearney J, Giovanucci E, Rimm EB et al. Calcium, vitamin D and dairy foods and the occurrence of colon cancer in men. Am. J. Epidemiol. 143(9), 907-917 (1996). (Pubitemid 26131098)
24. La Vecchia C, Braga C, Negri E et al. Intake of selected micronutrients and risk of colorectal cancer. Int. J. Cancer 73(4), 525-530 (1997). (Pubitemid 28005316)
25. Marcus PM, Newcomb PA. The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin women. Int. J. Epidemiol. 27(5), 788-793 (1998). (Pubitemid 28504965)
26. Levi, F, Pasche C, Lucchini F, La Vecchia C. Selected micronutrients and colorectal cancer. A case-control study from the canton of Vaud, Switzerland. Eur. J. Cancer 36(16), 2115-2119 (2000).
27. Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 11(5), 459-466 (2000). (Pubitemid 30345243)
28. Jarvinen R, Knekt P, Hakulinen T, Aromaa A. Prospective study on milk products, calcium and cancers of the colon and rectum. Eur. J. Clin. Nutr. 55(11), 1000-1007 (2001). (Pubitemid 33040098)
29. Terry P, Baron JA, Bergkvist L, Holmberg L, Wolk A. Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr. Cancer 43(1), 39-46 (2002). (Pubitemid 35387254)
30. McCullough ML, Robertson AS, Rodriguez C et al. Calcium, vitamin D, dairy products and risk of colorectal cancer in the Cancer Prevention Study II nutrition cohort (United States). Cancer Causes Control 14(1), 1-12 (2003). (Pubitemid 36403263)
31. Slattery ML, Neuhauser SL, Hoffman M et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int. J. Cancer 111(5), 750-756 (2004). (Pubitemid 39062899)
32. Lipworth L, Bender TJ, Rossi M et al. Dietary vitamin D intake and cancer of the colon and rectum: a case-control study in Italy. Nutr. Cancer 61(1), 70-75 (2009).
33. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 17(11), 2958-2969 (2008).
34. Holden JM, Lemar LE. Assessing vitamin D contents in foods and supplements: challenges and needs. Am. J. Clin. Nutr. 88(2), S551-S553 (2008).
35. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 8673(2), 1176-1178 (1989). (Pubitemid 19275448)
36. Braun MM, Helzlsouer KJ, Hollis BW, Comstock CW. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am. J. Epidemiol. 142(6), 608-611 (1995).
37. Tangrea J, Helzlsouer K, Pietinen P et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8(4), 615-625 (1997). (Pubitemid 27330494)
38. Niv Y, Sperber AD, Figer A et al. In colorectal carcinoma patients, serum vitamin D levels vary according to stage of the carcinoma. Cancer 86(3), 391-397 (1999). (Pubitemid 29347399)
39. Feskanich D, Ma J, Fuchs CS et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol. Biomarkers Prev. 13(9), 1502-1508 (2004). (Pubitemid 39202318)
40. Sieg J, Sieg A, Dreyhaupt J, Schmidt-Gayk H. Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis. Anticancer Res. 26(4A), 2729-2734 (2006).
41. Wactawski-Wende J, Katchen JM, Anderson GL et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354(7), 684-696 (2006). (Pubitemid 43247139)
42. Otani T, Iwaski M, Sasazuki S, Inoue M, Tsugane S, for the Japan Public Health Center-Based Prospective Study Group. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center- Based Prospective Study. Br. J. Cancer 97(3), 446-451 (2007). (Pubitemid 47196759)
43. Wu K, Feskanich D, Fuchs CS et al. A nested case-control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J. Natl Cancer Inst. 99(14), 1120-1129 (2007). (Pubitemid 47241396)
44. Jenab M, Bas Beueno-de-Mesquita H, Ferrari P et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. Br. Med. J. 340, b5500 (2010).
45. Woolcott CG, Wilkens LR, Nomura AMY et al. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev. 19(1), 130-134 (2010).
46. Levine AJ, Harper JM, Ervin CM et al. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr. Cancer 39(1), 35-41 (2001). (Pubitemid 32880946)
47. Peters U, McGlynn KA, Chatterjee N et al. Vitamin D, calcium and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 10(12), 1267-1274 (2001). (Pubitemid 34027758)
48. Grau MV, Baron JA, Sandler RS et al. Vitamin D, calcium supplementation and colorectal adenomas: results of a randomized trial. J. Natl Cancer Inst. 95(23), 1765-1771 (2003). (Pubitemid 38008899)
49. Peters U, Hayes RB, Chaterjee N et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev. 13(4), 546-552 (2004). (Pubitemid 38737889)
50. Jacobs ET, Alberts DS, Benuzillo J, Hollis BW, Thompson PA, Martinez ME. Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J. Steroid Biochem. Mol. Biol. 103(3-5), 752-756 (2007). (Pubitemid 46401330)
51. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment. Pharmacol. Ther. 30(2), 113-125 (2009).
52. IARC. Vitamin D and Cancer. IARC Working Group Reports Vol. 5, International Agency for Research on Cancer, Lyon, France, 25 November 2008.
53. Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl Cancer Inst. 99(21), 1594-1602 (2007).
54. Mezawa H, Sugiura T, Watanabe M et al. Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC Cancer 10, 347-355 (2010).
55. Ding EL, Mehta S, Fawzi WW, Giovannucci EL. Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial. Int. J. Cancer 122(8), 1690-1694 (2008). (Pubitemid 351413414)
56. Freedman DM, Rajaraman P, Fuhrman B, Hoffbeck R, Alexander BH. Sunlight, hormone replacement status and colorectal cancer risk in postmenopausal women. Int. J. Cancer 126(8), 1997-2001 (2010).
57. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ. 326(7387), 469 (2003).
58. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85(6), 1586-1591 (2007). (Pubitemid 46890428)
59. Ojha RP, Felini MJ, Fischbach LA. Vitamin D for cancer prevention: valid assertion or premature anoitment? Am. J. Clin. Nutr. 86(6), 1804-1805 (2007). (Pubitemid 350232200)
60. Schabas R. Artifact in the control group undermines the conclusions of a vitamin D and cancer study. Am. J. Clin. Nutr. 87(3), 792 (2008). (Pubitemid 351364563)
61. Fedirko V, Bostick RM, Flanders WD et al. Effects of vitamin D and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol. Biomarkers Prev. 18(11); 2933-2941 (2009).
62. Fedirko V, Bostick RM, Flanders WD et al. Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev. Res. 2(3), 213-223 (2009).
63. Fedirko V, Bostick RM, Long Q et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol. Biomarkers Prev. 19(1), 280-291 (2010).
64. Sidelnikov E, Bostick RM, Flanders WD et al. Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiol. Biomarkers Prev. 19(4), 1022-1032 (2010).
65. Holt PR, Bresalier RS, Ma CK, Liu KF, Lipkin M, Byrd JC, Yang K. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer 106, 287-296 (2006). (Pubitemid 43100436)
66. Holt PR, Arber N, Halmos B et al. Colonic epithelial cell proliferation decreased with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol. Biomarkers Prev. 11, 113-119 (2002). (Pubitemid 34118320)
67. Li WH, Gu Z, Wang H, Nekrutenko A. Evolutionary analyses of the human genome. Nature 409(6822), 847-849 (2001). (Pubitemid 32165341)
68. Rukin NJ, Strange RC. What are the frequency, distribution and functional effects of vitamin D receptor polymorphisms as related to cancer risk? Nutr. Rev. 65(8), S96-101 (2007).
69. Poytner JN, Jacobs ET, Figueiredo JC et al. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the colon cancer family registry. Cancer Epidemiol. Biomarkers Prev. 19(2), 525-536 (2010).
70. Egan JB, Thompson PA, Ashbeck EL et al. Genetic polymorphisms in vitamin D receptor VDR/RXR influence the likelihood of colon adenoma recurrence. Cancer Res. 70(4), 1496-1504 (2010).
71. Whitfield GK, Remus LS, Jurutka PW et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol. Cell. Endocrinol. 177(1-2), 145-159 (2001). (Pubitemid 32506815)
72. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30(7), 1170-1180 (2009).
73. McCullough ML, Bostick RM, Mayo TL. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Ann. Rev. Nutr. 29, 111-132 (2009).
74. Slattery ML, Murtaugh M, Caan B, Ma KN, Wolff R, Samowitz W. Associations between BMI, energy intake, energy expenditures, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control 15(9), 863-872 (2004). (Pubitemid 39663862)
75. Wong HL, Seow A, Arakawa K, Lee HP, Yu MC, Ingles SA. Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 24(6), 1091-1095 (2003). (Pubitemid 36827261)
76. Slattery ML, Wolff RK, Herrick JS, Caan BJ, Samowitz W. Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors. Nutr. Cancer 62(4), 436-442 (2010).
77. Wall JD, Prtichard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nat. Rev. Genet. 4(8), 587-597 (2003). (Pubitemid 36917501)
78. Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 16(12), 2752-2755 (2007). (Pubitemid 351196332)
79. Dong LM, Ulrich CM, Hsu L et al. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol. Biomarkers Prev. 18(19), 2540-2548 (2009).
80. Beaty MM, Lee EY, Glauert HP. Influence of dietary calcium and vitamin D on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets. J. Nutr. 123(1), 144-152 (1993). (Pubitemid 23035241)
81. Akhter J, Chen X, Bowrey P, Bolton EJ, Morris DL. Vitamin D3 analog, EB 1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model. Dis. Colon Rectum 40(3), 317-321 (1997). (Pubitemid 27120140)
82. Yang K, Lamprecht SA, Shinozaki H et al. Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice. J. Nutr. 138(9), 1658-1663 (2008).
83. Tangpricha V, Spina C, Yao M, Chen TC, Wolfe MM, Holick MF. Vitamin D enhances the growth of MC-26 colon cancer xenografts in Balb/C mice. J. Nutr. 135(10), 2350-2354 (2005). (Pubitemid 41429589)
84. Ordonez-Moran P, Larriba MJ, Pendas- Franco N, Aguilera O, Gonzalez-Sancho JM, Munoz A. Vitamin D and cancer: an update on in vitro and in vivo data. Front. Biosci. 10, 2723-2749 (2005). (Pubitemid 40908912)
85. Gonzalez-Sancho JM, Larriba MJ, Ordonez-Moran P, Palmer HG, Munoz A. Effects of 1-a,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res. 26(4A), 2669-2681 (2006). (Pubitemid 44155548)
86. Gocek E, Studzinski GP. Vitamin D and differentiation in cancer. Crit. Rev. Clin. Lab. Sci. 46(4), 190-209 (2009).
87. Halline AG, Davidson NO, Skarosi SF et al. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells. Endocrinology 134(4), 1710-1717 (1994). (Pubitemid 24110727)
88. Tong WM, Bises G, Shenin Y et al. Establishment of primary cultures from human colonic tissue during tumor progression: vitamin-D responses and vitamin-D-receptor expression. Int. J. Cancer 75(3), 467-472 (1998). (Pubitemid 28100052)
89. Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implicationso prevention and therapy. Cancer Res. 60(8), 2304-2312 (2000). (Pubitemid 30225198)
90. Pendas-Franco N, Aguilera O, Pereira F, Gonzalez-Sancho JM, Munoz A. Vitamin D and Wnt/b-catenin pathway in colon cancer: role and regulation of Dickkopf genes. Anticancer Res. 28(5A), 2613-2624 (2008).
91. Saif MW, Chu E. Biology of colorectal cancer. Cancer J. 16(3), 196-201 (2010).
92. Beildeck ME, Islam M, Shah S, Welsh J, Byers SW. Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines. PLoS One 4(11), e7872 (2009).
93. Egan JB, Thompson PA, Vitanov MV et al. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor Fok1 polymorphism collectively modulate b-catenin activity in colon cancer cells. Mol. Carcinogenesis 49, 337-352 (2010).
94. Palmer HG, Gonzalez-Sancho JM, Espada J et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of b-catenin signaling. J. Cell. Biol. 154(2), 369-387 (2001). (Pubitemid 34286147)
95. Pendas-Franco N, Garcia JM, Pena C et al. Dickkopf-4 is induced by TCF/b-catenin and upregulated in human colon cancer, promotes tumor cell invasion and angiogenesis and is repress by 1-a,25- dihydroxyvitamin D3. Oncogene 27(32), 4467-4477 (2008).
96. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84(3), 345-357 (1996). (Pubitemid 26058560)
97. Ordonez-Moran P, Larriba MJ, Palmer HG et al. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression phenotype and Wnt pathway in colon cancer cells. J. Cell. Biol. 138(4), 697-710 (2008).
98. Shah S, Islam MN, Dakshanamurthy S et al. The molecular basis of vitamin D receptor and b-catenin transcriptional activity. Mol. Cell. 21(6), 799-809 (2006). (Pubitemid 43376130)
99. Nelson WJ, Nusse R. Convergence of Wnt, b-catenin, and cadherin pathways. Science 303(5663), 1483-1487 (2004). (Pubitemid 38314410)
100. Kaler, P, Augenlicht L, Kampfer L. Macrophage-derived IL-1b stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene 28(44), 3892-3902 (2009).
101. Cross HES, Nittke T, Peterlik M. Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention. Anticancer Res. 29(9), 3705-3712 (2009).
102. Chakrabarty S, Wang H, Canaff L, Hendy GN, Appelman H, Varani J. Calcium sensing receptor in human colon carcinoma: interaction with Ca and 1,25-dihydroxyvitamin D3. Cancer Res. 65(2), 493-498 (2005).
103. Liu G, Hu X, Chakrabarty S. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and surviving and promotes cellular sensitivity to 5-FU. Int. J. Cancer 126(3), 631-639 (2010).
104. Cross HS, Kallay E. Regulation of the colonic vitamin D system for prevention of tumor progression: an update. Future Oncol. 5(4), 493-507 (2009).
105. Horvath HC, Lakatos P, Kosa JP et al. The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J. Histochem. Cytochem. 58(3), 277-285 (2010).
106. Campbell FC, Xu H, El-Tanani M, Crowe P, Bingham V. The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem. Pharmacol. 79(1), 1-9 (2010).
107. Sheinin Y, Kaserer K, Wrba F et al. In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch. 437(5), 501-507 (2000).
108. Cross HS, Bareis P, Hofer H et al. 25-hydroxyvitamin D(3)-1a-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66(3-5), 287-292(2001). (Pubitemid 32140906)
109. Palmer HG, Larriba MJ, Garcia JM et al. The transcription factor Snail represses vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med. 10(9), 917-919 (2004). (Pubitemid 39273731)
110. Pena C, Garcia JM, Silva J et al. E-cadherin and vitamin D receptor regulation by Snail and ZEB1 in colon cancer: clinicophathological correlations. Hum. Mol. Genet. 14(22), 3361-3370 (2005). (Pubitemid 41672120)
111. Larriba MJ, Munoz A. Snail vs vitamin D receptor expression in colon cancer: therapeutics implications. Br. J. Cancer 92(6), 985-989 (2005). (Pubitemid 40546657)
112. Larriba MJ, Bonilla F, Munoz A. The transcriptional factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression. J. Steroid Biochem. Mol. Biol. 121(1-2), 106-109 (2010).
113. Larriba MJ, Valle N, Palmer HG et al. The inhibition of Wnt/b-catenin signaling by 1-a,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells. Endocr. Relat. Cancer 14(1), 141-151 (2007). (Pubitemid 47521730)
114. Larriba MJ, Martin-Villar E, Garcia JM et al. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis. 30(8), 1459-1468 (2009).
115. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2), 83-95 (2005). (Pubitemid 40691207)
116. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D inn C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 30(1), 88-92 (2009).
117. Yang K, Lamprecht SA, Shinozaki H et al. Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli 1638 N/+ mice. J. Nutr. 138(9), 1658-1663 (2009).
118. Grau MV, Baron JA, Sandler RS et al. Vitamin D, calcium supplementation and colorectal adenomas: results of a randomized trial. J. Natl Cancer Inst. 95(23), 1765-1771 (2003). (Pubitemid 38008899)
119. Cross HS. Extrarenal vitamin hydroxylase expression and activity in normal and malignant cells: modification of expression by epigenetic mechanisms and dietary substances. Nutr. Rev. 65(8 Pt 2), S108-S112 (2007).
120. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J. Nutr. 134(5), S1207-S1212 (2004).
121. Looker AC. Do body fat and exercise modulate vitamin D status? Nutr. Rev. 65(8 Pt 2), S124-S126 (2007).
122. Samad AKA, Taylor RS, Marshall T, Chapman MAS. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Disease 7(3), 204-213 (2005). (Pubitemid 40637417)
123. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate and pancreas. Gastroenterology 132(6), 2208-2225 (2007). (Pubitemid 46693749)
124. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J. Nutr. Biochem. 17(3), 145-156 (2006). (Pubitemid 43247408)
125. Toner CD, Davis CD, Milner JA. The vitamin D and cancer conundrum: aiming at a moving target. J. Am. Diet. Assoc. 110(10), 1492-1500 (2010).